Indication
Myeloid Tumor
2 clinical trials
4 products
Product
IBI322Clinical trial
A Phase Ia/Ib Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Myeloid TumorStatus: Terminated, Estimated PCD: 2023-06-19
Clinical trial
Shanghai General Hospital Affiliated to Shanghai Jiao Tong UniversityStatus: Completed, Estimated PCD: 2023-08-23
Product
ATG/PTCyProduct
ATGProduct
PTCy